Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PharmaCyte Biotech (PMCB) Shares Issued (2016 - 2023)

PharmaCyte Biotech (PMCB) has disclosed Shares Issued for 13 consecutive years, with $70.0 as the latest value for Q3 2023.

  • On a quarterly basis, Shares Issued fell 92.05% to $70.0 in Q3 2023 year-over-year; TTM through Apr 2024 was $70.0, a 92.05% decrease, with the full-year FY2024 number at $70.0, down 92.05% from a year prior.
  • Shares Issued was $70.0 for Q3 2023 at PharmaCyte Biotech, down from $880.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $55.7 million in Q2 2022 to a low of -$24.0 million in Q1 2022.
  • A 5-year average of $5.7 million and a median of $482500.0 in 2019 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 1482.53% in 2021; the steepest drop was 1144.28% in 2021.
  • PharmaCyte Biotech's Shares Issued stood at $301000.0 in 2019, then soared by 844.14% to $2.8 million in 2020, then soared by 1482.53% to $45.0 million in 2021, then crashed by 100.0% to $880.0 in 2022, then tumbled by 92.05% to $70.0 in 2023.
  • Per Business Quant, the three most recent readings for PMCB's Shares Issued are $70.0 (Q3 2023), $880.0 (Q3 2022), and $55.7 million (Q2 2022).